Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeTadej Battelino, Moshe Phillip, Thomas Danne et al.|Diabetes Care|2019Cited by 3.8k
International Consensus on Use of Continuous Glucose MonitoringThomas Danne, Moshe Phillip, Revital Nimri et al.|Diabetes Care|2017Cited by 2k
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal InsulinThomas W. Martens, Amy Change, Guillermo E. Umpierrez et al.|JAMA|2021Cited by 491
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical PracticeMoshe Phillip, David C. Klonoff, Revital Nimri et al.|Endocrine Reviews|2022Cited by 398
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized TrialVanita R. Aroda, Julio Rosenstock, Carol Wysham et al.|Diabetes Care|2016Cited by 254